Kezar Life Sciences, Inc.KZRNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank78
3Y CAGR+9.1%
5Y CAGR+25.8%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+9.1%/yr
vs +17.0%/yr prior
5Y CAGR
+25.8%/yr
Recent deceleration
Acceleration
-7.9pp
Decelerating
Percentile
P78
Within normal range
vs 5Y Ago
3.1x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$3.80M-44.7%
2024$6.87M-28.1%
2023$9.55M+226.9%
2022$2.92M+9979.3%
2021$29000.00-97.6%
2020$1.21M-46.4%
2019$2.25M+44.6%
2018$1.56M+572.0%
2017$232000.00-
2016$0.00-